TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Strata Skin Sciences ( (SSKN) ) has shared an announcement.
On November 13, 2025, STRATA Skin Sciences announced its financial results for the third quarter of 2025, reporting a decline in total revenue by approximately $1.9 million due to international market instability. Despite this, the company made significant progress in expanding CPT codes for reimbursement, which is expected to triple the covered patient population in the US. The company also reported positive developments in its ongoing lawsuit against LaserOptek, which could lead to increased revenue. STRATA’s gross margin remained stable at 60%, and the company ended the quarter with $7.1 million in cash.
The most recent analyst rating on (SSKN) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
The overall stock score is primarily impacted by the company’s financial challenges and bearish technical indicators. While there are some positive strategic initiatives and market expansion potential, these are overshadowed by ongoing losses, valuation concerns, and weak market momentum.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
STRATA Skin Sciences, Inc. is a medical technology company focused on developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions. The company is known for its XTRAC Excimer Laser system, which is used in the treatment of various skin disorders, and TheraClearX, which has recently been cleared for use in Mexico.
Average Trading Volume: 4,927,247
Technical Sentiment Signal: Sell
Current Market Cap: $9.55M
Learn more about SSKN stock on TipRanks’ Stock Analysis page.